Skip to content

Effects of Ultrasound and Fluoroscopy guided injection in Ankylosing Spondylitis and related diseases.

A comparative study between the clinical effect of Ultrasound versus Fluoroscopy guided Sacroiliac Joint injection in Spondyloarthropathy.

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/07/026854
Enrollment
52
Registered
2020-07-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M45-M49- Spondylopathies

Interventions

Intervention1: Ultrasound guided injection in Sacroiliac joint : Ultrasound guided Lignocaine and Corticosteroid injection in Sacroiliac joint Control Intervention1: Fluoroscopy guided injection in S

Sponsors

R G Kar Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed case of seronegative Spondyloarthropathy by ASAS criteria. 2. Pain primarily experienced between the upper level of the iliac crests and the gluteal fold. 3. Active sacroilitis clinically (positive finding of at least 3 of 6 following tests for SIJ pain) i. Distraction or â??Gappingâ?? ii. FABER/Patrickâ??s Test iii. Thigh Thrust or Posterior Pelvic Pain Provocational Test iv. Gaenslenâ??s Test v. Sacroiliac Joint Compression Test vi. Sacral Thrust or Yeomanâ??s Test. 4. Poorly controlled by conservative treatment for 1 month by means of both pharmacological and non-pharmacological therapy. 5. Age between 18-45 years. 6. Oswestry disability index > 40% 7. NRS (0-10) > 5. 8. Reduction of pain intensity by > 75% following a diagnostic injection. 9. Unilateral sacroilitis.

Exclusion criteria

Exclusion criteria: 1. Severe peripheral arthritis with hip involvement. 2. Clinical findings and imaging studies suggest other obvious cause of the pain (e.g., central spinal stenosis with neurogenic claudication/myelopathy, foraminal stenosis or disc herniation with concordant radicular pain/radiculopathy, pyriformis syndrome, infection, tumour, fracture, pain related to spinal instrumentation). 3. Degenerative sacroiliac joint or complete ankylosis of sacroiliac joint (Grade IV). 4. Patient assume prone lying position to be difficult. 5. Allergy to lignocaine, contrast dye. 6. Presence of coagulation disorder or receiving anti-coagulant therapy. 7. With other systemic disorders or active infection or other contraindications for corticosteroid injection. 8. Unwilling patient. 9. Patient unable to come to hospital for subsequent visits for follow-up. 10. Has current skin disease over the injection site. 11. Has psychiatric disorder. 12. H/o prior injection in SIJ within 2 months.

Design outcomes

Primary

MeasureTime frame
1.Severity of sacroiliac joint pain - measured by NRS (Numeric Rating Scale) [0-10]Timepoint: Baseline 1 Week 4 Weeks 12 Weeks

Secondary

MeasureTime frame
Disability due to low back pain - measured by Oswestry disability indexTimepoint: Baseline 1 Week 4 Weeks 12 Weeks

Countries

India

Contacts

Public ContactProf DR Pankaj Kumar Mandal

R. G. Kar Medical College and Hospital

ghosh.debajyoti2010@gmail.com9153093649

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026